SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002149
Filing Date
2021-03-01
Accepted
2021-03-01 16:02:23
Documents
80
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tgtx-20201231x10k.htm   iXBRL 10-K 2725780
2 EX-4.5 tgtx-20201231xex4d5.htm EX-4.5 76689
3 EX-21.1 tgtx-20201231xex21d1.htm EX-21.1 4356
4 EX-23.1 tgtx-20201231xex23d1.htm EX-23.1 2411
5 EX-31.1 tgtx-20201231xex31d1.htm EX-31.1 13662
6 EX-31.2 tgtx-20201231xex31d2.htm EX-31.2 13633
7 EX-32.1 tgtx-20201231xex32d1.htm EX-32.1 6676
8 EX-32.2 tgtx-20201231xex32d2.htm EX-32.2 6614
9 GRAPHIC tgtx-20201231x10k001.jpg GRAPHIC 40171
  Complete submission text file 0001558370-21-002149.txt   9257802

Data Files

Seq Description Document Type Size
10 EX-101.SCH tgtx-20201231.xsd EX-101.SCH 57075
11 EX-101.CAL tgtx-20201231_cal.xml EX-101.CAL 65499
12 EX-101.DEF tgtx-20201231_def.xml EX-101.DEF 199141
13 EX-101.LAB tgtx-20201231_lab.xml EX-101.LAB 525206
14 EX-101.PRE tgtx-20201231_pre.xml EX-101.PRE 379353
15 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20201231x10k_htm.xml XML 1541191
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 21697622
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences